Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Omnipod 5 Implementation in Belgian Paediatric Diabetes Care

NCT: NCT07785037 · NOT_YET_RECRUITING

NCT IDNCT07785037
StatusNOT_YET_RECRUITING
Start Date2026-09-01
Completion2027-12-31
SponsorQueen Fabiola Children's University Hospital (OTHER)
First posted
Last updated

Brief Summary

This study will evaluate the introduction and use of the Omnipod® 5 hybrid closed-loop insulin delivery system in children and adolescents with type 1 diabetes following its reimbursement in Belgium. The study will describe how quickly the system is adopted in routine paediatric diabetes care, which patients are offered this technology, and the reasons for choosing Omnipod® 5. It will also evaluate changes in the use of different insulin pump systems and assess diabetes control, safety, and continued use of Omnipod® 5 during follow-up. The study is observational, meaning that participants will receive their usual diabetes care and their treatment will not be changed for research purposes. Information collected during routine diabetes follow-up, including glucose sensor, insulin pump, and medical record data, will be analysed. No additional examinations, blood tests, or hospital visits will be required for participation.

Frequently Asked Questions

What is Omnipod 5 Implementation in Belgian Paediatric Diabetes Care?

Omnipod 5 Implementation in Belgian Paediatric Diabetes Care is a clinical trial registered under NCT07785037. Current status: NOT_YET_RECRUITING.

What is the status of NCT07785037?

The current status of NCT07785037 (Omnipod 5 Implementation in Belgian Paediatric Diabetes Care) is: NOT_YET_RECRUITING.

When did Omnipod 5 Implementation in Belgian Paediatric Diabetes Care start?

Omnipod 5 Implementation in Belgian Paediatric Diabetes Care started on 2026-09-01.

Related Devices

PMA P130007Pump, infusion, insulin, to be used with invasive glucose sensorAnimas Corp. K191679Omnipod DASH Insulin Management System with interoperable technologyInsulet Corporation K201214t:slim X2 Insulin Pump with Interoperable TechnologyTandem Diabetes Care, Inc. K232380t:slim X2 Insulin Pump with Interoperable TechnologyTandem Diabetes Care, Inc. K250792t:slim X2 insulin pump with interoperable technologyTandem Diabetes Care, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑